Linical Co., Ltd. (2183.T) JPX

220.00

+1(+0.46%)

Updated at June 03 03:17PM

Currency In JPY

Linical Co., Ltd.

Address

Shin-Osaka Brick Building

Osaka, 532-0003

Japan

Phone

81 6 6150 2478

Sector

Healthcare

Industry

Biotechnology

Employees

662

First IPO Date

October 27, 2008

Key Executives

NameTitlePayYear Born
Kazuhiro HatanoPresident, Chief Executive Officer, Chief Strategy Officer, Chief Commercial Officer & Representative Director01965
Tracy GoekenChief Medical Officer0N/A
Toshiaki NagafujiExecutive Officer, Chief Technology Officer & Head of Innovative Drug Development Business Unit (HQ, Japan)0N/A
Tokuno MasayoshiExecutive Officer & Chief Information Officer0N/A
Akihiro TakahashiExecutive Officer & CFO01967
Jun KawaiExecutive Officer, Chief Clinical Operation Officer & Chief Administrative Officer01968
Keigo TsujimotoExecutive Officer & Chief Project Officer01964
Satoru ToyotaExecutive Officer & Head of Oncology Business Unit (HQ, Japan)0N/A
Clareece WestPresident & Chief Commercial Officer of Americas & Europe0N/A
Shiori YamaguchiExecutive Officer & CCO01975
Masaya MiyazakiExecutive Officer, APAC-Chief Commercial Officer & Chief Asia Pacific Officer01971

Description

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.